Resveratrol in the Prevention and Treatment of Coronary Artery Disease
Resveratrol is a polyphenolic compound found in red wine that is believed to be responsible for its beneficial cardiovascular effects. Extensive research in the past several decades has identified multiple mechanisms by which resveratrol modifies the cardiovascular risk factors that lead to coronary artery disease, yet translation to the clinical arena has been unexpectedly slow. In this article, we review the existing evidence regarding the beneficial effects of resveratrol and briefly discuss its potential therapeutic applications.
KeywordsResveratrol Coronary artery disease Atherosclerosis Cholesterol Metabolic syndrome Ischemia-reperfusion Chronic ischemia Angiogenesis Antioxidant
L.M. Chu: none; A.D. Lassaletta: none; M.P. Robich: none; F.W. Sellke: consultant for NovoNordisk and Cubist Pharmaceuticals, expert testimony for Pfizer in litigation regarding Celebrex.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 2011;123(4):e18–209. This article details the most recent national statistics for coronary artery disease and other cardiovascular diseases. PubMedCrossRefGoogle Scholar
- 14.•• Do GM, Kwon EY, Kim HJ, et al. Long-term effects of resveratrol supplementation on suppression of atherogenic lesion formation and cholesterol synthesis in apo E-deficient mice. Biochem Biophys Res Commun. 2008;374(1):55–9. This work elegantly summarized the effects of resveratrol on serum cholesterol and its components, and relates those effects to pathologic findings. PubMedCrossRefGoogle Scholar
- 16.•• Robich M, Osipov R, Nezafat R, et al. Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation 2010;122(11 Suppl):S142–9. This is the only work to date investigating the effects of resveratrol supplementation on angiogenesis and myocardial perfusion in the setting of ongoing myocardial ischemia.PubMedCrossRefGoogle Scholar
- 25.• Deng YH, Alex D, Huang HQ, et al. Inhibition of TNF-α-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,4′-trimethoxystilbene. Phytother Res. 2011;25(3):451–7. This is an elegant study showing the effects of resveratrol on monocyte recruitment and activation.PubMedGoogle Scholar
- 27.Chung EY, Kim BH, Hong JT, et al. Resveratrol down-regulates interferon-γ-inducible inflammatory genes in macrophages: molecular mechanism via decreased STAT-1 activation. J Nutr Biochem. 2010(Epub ahead of print).Google Scholar
- 39.•• Kim S, Jin Y, Choi Y, et al. Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol. 2011;81(11):1343–51. This study details several possible molecular mechanisms for the anti-obesity effects of resveratrol.PubMedCrossRefGoogle Scholar
- 45.•• Mukhopadhyay P, Mukherjee S, Ahsan K, et al. Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One. 2010;5(12):e15705. This is one of the few studies examining the protective effects of resveratrol against ischemia-reperfusion injury, and it reports a unique mechanism for these effects.PubMedCrossRefGoogle Scholar